Financial reports
10-Q
2024 Q2
Quarterly report
14 Feb 24
10-Q
2024 Q1
Quarterly report
14 Nov 23
10-K/A
2023 FY
Annual report (amended)
30 Oct 23
10-K
2023 FY
Annual report
2 Oct 23
NT 10-K
Notice of late annual filing
29 Sep 23
10-Q
2023 Q3
Quarterly report
12 May 23
10-Q
2023 Q2
Quarterly report
9 Mar 23
10-Q
2023 Q1
Quarterly report
7 Mar 23
10-K
2022 FY
Annual report
27 Feb 23
NT 10-Q
Notice of late quarterly filing
15 Nov 22
Current reports
8-K
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
24 Apr 24
8-K/A
Financial Statements and Exhibits
24 Apr 24
8-K
Departure of Directors or Certain Officers
13 Mar 24
8-K
Termination of a Material Definitive Agreement
7 Mar 24
8-K
Departure of Directors or Certain Officers
5 Mar 24
8-K
Other Events
16 Feb 24
8-K
Entry into a Material Definitive Agreement
14 Feb 24
8-K
Amendments to Articles of Incorporation or Bylaws
7 Feb 24
8-K
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
25 Jan 24
8-K
Other Events
16 Jan 24
Registration and prospectus
D
Exempt offering of security
23 Feb 24
S-8
Registration of securities for employees
20 Oct 23
425
Business combination disclosure
2 Oct 23
425
Business combination disclosure
29 Sep 23
S-3/A
Shelf registration (amended)
3 Mar 22
S-3
Shelf registration
11 Feb 22
S-8
Registration of securities for employees
13 Dec 21
424B5
Prospectus supplement for primary offering
16 Jun 21
424B5
Prospectus supplement for primary offering
20 Jul 20
S-3/A
Shelf registration (amended)
16 Jul 20
Proxies
DEFA14A
Additional proxy soliciting materials
16 Jan 24
DEFA14A
Additional proxy soliciting materials
16 Jan 24
DEFM14A
Proxy related to merger
3 Jan 24
PREM14A
Preliminary proxy related to merger
22 Dec 23
DEFA14A
Additional proxy soliciting materials
22 Dec 23
DEFA14A
Additional proxy soliciting materials
11 Dec 23
DEFA14A
Additional proxy soliciting materials
7 Dec 23
DEFA14A
Additional proxy soliciting materials
1 Dec 23
DEFA14A
Additional proxy soliciting materials
1 Dec 23
DEFA14A
Additional proxy soliciting materials
22 Nov 23
Other
UPLOAD
Letter from SEC
9 Jun 23
EFFECT
Notice of effectiveness
9 Mar 22
CORRESP
Correspondence with SEC
4 Mar 22
UPLOAD
Letter from SEC
18 Feb 22
EFFECT
Notice of effectiveness
21 Jul 20
CORRESP
Correspondence with SEC
16 Jul 20
UPLOAD
Letter from SEC
16 Jul 20
UPLOAD
Letter from SEC
10 Apr 20
CORRESP
Correspondence with SEC
9 Mar 20
UPLOAD
Letter from SEC
11 Feb 20
Ownership
SC 13D/A
William Anderson Wittekind
8 Apr 24
4
JAMES SAPIRSTEIN
19 Mar 24
4
Simon Tarsh
13 Mar 24
3
Simon Tarsh
13 Mar 24
4
Carol L Brosgart
28 Feb 24
3
Karen Brink
23 Feb 24
4
Rene Sindlev
22 Feb 24
SC 13G/A
Abildgaard Ole
22 Feb 24
4
Ole Abildgaard
20 Feb 24
SC 13D/A
William Anderson Wittekind
16 Feb 24